Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of vaginal bromocriptine versus oral cabergoline for hyperprolactinemia in infertile women
PACTR202105785593643Completed
- Sponsor
- Irshad Asma
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in hyperprolactinemia and female infertility comparing Oral cabergoline with Vaginal bromocriptine (2 arms). Primary endpoints: Percentage fall in serum prolactin levels and Proportion with side effects. Started Nov 2020; status: completed.
02
Drugs
cabergolinebromocriptine
03
Conditions
hyperprolactinemiafemale infertility
Beyond the preview
Go deeper on PACTR202105785593643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202105785593643.